JFG
FOLD

Jefferies Financial Group’s Amicus Therapeutics FOLD Stock Holding History

Jefferies Financial Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,300
Closed -$583K – 1787
2026
Q1 		$583K Sell
40,300
-125,185
-76% -$1.79M ﹤0.01% 1143
2025
Q4 		$2.36M Hold
165,485
– – 0.01% 743
2025
Q3 		$1.3M Sell
165,485
-58,315
-26% -$415K 0.01% 778
2025
Q2 		$1.28M Buy
223,800
+35,903
+19% +$232K 0.01% 649
2025
Q1 		$1.53M Buy
+187,897
New +$1.74M 0.01% 654
2024
Q1 		– Sell
-29,494
Closed -$419K – 1742
2023
Q4 		$419K Sell
29,494
-24,279
-45% -$276K ﹤0.01% 1286
2023
Q3 		$654K Sell
53,773
-38,512
-42% -$497K 0.01% 964
2023
Q2 		$1.16M Buy
+92,285
New +$1.1M 0.01% 860

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Jefferies Financial Group's FOLD Position: Q2 2026 in Review

Jefferies Financial Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 40,300 shares — an estimated $583K sold.

Jefferies Financial Group first reported a position in FOLD in Q2 2023 and held it in 8 quarters. The position peaked at $2.36M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Jefferies Financial Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 40,300 Amicus Therapeutics shares in Q2 2026, an estimated $583K.
  • Jefferies Financial Group first reported a position in Amicus Therapeutics in Q2 2023 and held it in 8 quarters.
  • Jefferies Financial Group's Amicus Therapeutics position peaked at $2.36M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.